Primary vaccine failure after 1 dose of varicella vaccine in healthy children. - Wikidata - wikimedia - TriplyDB

Primary vaccine failure after 1 dose of varicella vaccine in healthy children.

Primary vaccine failure after 1 dose of varicella vaccine in healthy children.

http://www.wikidata.org/entity/Q37131910

about

Vaccinology in the third millennium: scientific and social challenges Microbiology laboratory and the management of mother-child varicella-zoster virus infection Varicella zoster vaccines and their implications for development of HSV vaccines Evaluation of the time resolved fluorescence immunoassay (TRFIA) for the detection of varicella zoster virus (VZV) antibodies following vaccination of healthcare workers Impact of varicella vaccine on varicella-zoster virus dynamics Varicella and varicella vaccination in South Korea Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses Determinants of varicella breakthrough: results of a 2012 case control study.Detection of antibodies to varicella-zoster virus in recipients of the varicella vaccine by using a luciferase immunoprecipitation system assay.Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.Effectiveness of 2 doses of varicella vaccine in children.Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses How to design effective vaccines: lessons from an old success story Safety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: a randomized controlled study.Failure of a Single Varicella Vaccination to Protect Children With Cancer From Life-Threatening Breakthrough Varicella.Antibody induced by one-dose varicella vaccine soon became weak in children: evidence from a cross-sectional seroepidemiological survey in Beijing, PRC Serological Evaluation of Immunity to the Varicella-Zoster Virus Based on a Novel Competitive Enzyme-Linked Immunosorbent Assay Seroepidemiology of varicella-zoster virus in Korea.Healthcare workers' knowledge and practices regarding expanded program on immunization in Kalasin, Thailand Varicella outbreak in the patients during group therapy: seroprevalence in a healthcare system during breakthrough varicella occurrence.Vaccines: correlates of vaccine-induced immunity.Pathogenesis and current approaches to control of varicella-zoster virus infections.Breakthrough varicella in a cancer patient with persistent varicella antibody after one varicella vaccination.Varicella: efficacy of two-dose vaccination in childhood.Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre, Spain.Vaccination against varicella: what's the point?Correlates of protection induced by vaccination.Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D.Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?Control of varicella in the post-vaccination era in Australia: a model-based assessment of catch-up and infant vaccination strategies for the future.Perspectives on vaccines against varicella-zoster virus infections.The impact of vaccine success and awareness on epidemic dynamics.A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella.Evaluation of immunity to varicella zoster virus with a novel double antigen sandwich enzyme-linked immunosorbent assay.The impact of vaccine failure rate on epidemic dynamics in responsive networks.Evaluation of a commercial glycoprotein enzyme-linked immunosorbent assay for measuring vaccine immunity to varicella.Varicella-zoster virus-specific, cell-mediated immunity with interferon-gamma release assay after vaccination of college students with no or intermediate IgG antibody response.Zoster vaccine recommendations: the importance of using a clinically valid correlate of protection.Comparative study of the standard fluorescent antibody to membrane antigen (FAMA) assay and a flow cytometry-adapted FAMA assay to assess immunity to varicella-zoster virus.Varicella Virus Vaccination in the United States.

P2860

Q24261399-8AB031AE-239B-45E0-AA59-3F6D26AD8FB4 Q26738745-A2293D12-76C5-4EEF-83D7-69013B05BA38 Q28280820-76721649-C374-489B-9BF8-AA6998B46B74 Q33562829-C53268E2-BD49-4593-88EE-AD72F3660C41 Q33591264-B89DA1EE-7987-4EFE-89F9-9EF6BAAB7640 Q33601820-7B703AE8-BBCD-4CDE-B31A-6E786FE574C1 Q33880341-4AFA2AB6-1940-4546-A820-3AABF5BDB9C7 Q34033922-6D332E2E-3895-444C-9348-DC85956B49DE Q34260743-F7BC5D2B-A816-423A-82BF-31B830F00A13 Q34683751-734B15A2-2501-41F9-9751-58C2C9814813 Q34763888-366EB7C6-7DF5-494F-B856-817D08238289 Q35105463-C93244FD-F0F1-4628-997C-EBB97D8814FE Q35118610-9768F78C-9BD5-4967-A3CD-04A0E1B0552B Q35887597-937502EB-5444-4D11-A7E3-42744C0100E4 Q35939962-25468332-C504-489D-9D0B-321E01016500 Q36270547-7F7B7F69-8DFB-47FD-92AA-0D7C1D4DB42A Q36555118-7389655F-13F6-42C0-86CE-ED5A5827CDF2 Q36589458-79274AA7-7196-43D5-B0BA-1BEFD3A65BEF Q36797066-08805D44-D792-4EAC-B9D4-72C9EAA5292A Q37011005-8A0624E0-98FB-4FE0-BFFB-09DBAE43E1CB Q37193062-1D53B241-93B6-4490-8016-59E7AB4E5AB8 Q37263293-1409D7A9-CE52-4225-A2B2-016C2FBC2ED8 Q37265904-AB812CD4-B025-493B-8469-9871B84BFB09 Q37496720-B877A25C-1B69-4E76-AFD4-B5CED27BD717 Q37505437-9B4FF5F3-6277-4AB3-A3D8-530CA14C792F Q37703012-10A36CE0-ED56-4176-AB3F-79E3BA15D2EC Q37750121-798B0DF9-2C58-4804-BCD4-4029A695B137 Q38241377-8A94DF9D-A51C-4293-91FD-C97B3D04AEC9 Q38667215-730C31CC-0508-4914-A2C3-7F4535189236 Q39128973-3BE1C084-0E05-4D6E-BA47-CBE6606004E6 Q40363716-BC4CD06E-1D17-44F8-93AF-E6DCB4216FFF Q40427373-1BECBD97-BA9E-4BBA-9FA9-75EA8B89BAF3 Q40499818-11C3884D-398C-435E-98FC-147A43A24421 Q40540257-84B63D47-2F0A-4D23-B939-4727C3483E3D Q41266138-355DF98E-5C6F-4B7D-8A4E-5D3CFB9FCB7B Q41982145-AF546472-2C5D-48AE-A005-3ED3143231AB Q42202653-F0CF4408-3444-4709-8EB3-B841D76A4778 Q42366475-97755C8B-E9DE-412F-BC18-F8D22F68229E Q42849184-4F722E76-E3F6-4855-82F1-7AF2EFE22377 Q45324301-11E62879-7102-4824-A10D-00D5220BF735

P2860

Primary vaccine failure after 1 dose of varicella vaccine in healthy children.

http://www.wikidata.org/entity/Q37131910

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Primary vaccine failure after 1 dose of varicella vaccine in healthy children.

@en

Primary vaccine failure after 1 dose of varicella vaccine in healthy children.

@nl

type

label

Primary vaccine failure after 1 dose of varicella vaccine in healthy children.

@en

Primary vaccine failure after 1 dose of varicella vaccine in healthy children.

@nl

prefLabel

Primary vaccine failure after 1 dose of varicella vaccine in healthy children.

@en

Primary vaccine failure after 1 dose of varicella vaccine in healthy children.

@nl

P1433

Q37131910-76ADE59F-1A5A-475A-9C0A-6085F887D141

P1476

Q37131910-FEC728F3-D1A4-4651-B181-CAB4B6368B7E

P2093

Q37131910-3117ED28-21A9-420F-A454-AADCF4168DB9

Q37131910-3CEB748F-242C-4CED-B72A-01A7C4FAC276

Q37131910-89D5D799-ADAB-47C8-9C2C-5ED3152BF89B

Q37131910-90C59A36-8D4A-47D7-8894-CBE086698A4E

Q37131910-A18EFEB3-C874-40CA-9111-4F155CF4121A

Q37131910-AF61221C-6BA2-4D47-9995-A0C57354642F

Q37131910-C6F0AC41-2711-4E34-A837-A4CCE6C63F05

P2860

Q37131910-049D7A01-C628-4AE7-BD9F-15D9F7A3A52E

Q37131910-07596BD2-C67D-4A4E-A80E-69B8F4265901

Q37131910-15099186-F8DA-479F-BF42-8BD8A5F267CC

Q37131910-25CBB7EB-B64D-4CC9-9ECA-D9FAF3101E25

Q37131910-35DAE287-99EC-4216-8246-886637CD0ADD

Q37131910-3B444EE9-33FE-4F88-96D5-405310CA83DB

Q37131910-3DA171BD-DBA6-45E5-8DC7-B1AD6E04F230

Q37131910-6EDF6BF8-4390-466E-B22C-5D25F36EB1E3

Q37131910-748C9BA8-9DE7-4A5A-A313-8846027022C4

Q37131910-74B07122-8E74-4994-BC4D-F2CCF0622D83

P304

Q37131910-7B3F11BD-BE8A-47FB-84BC-42B781B6BF28

P31

Q37131910-0AE8A919-7727-4D9E-9050-E5C567406AF6

P356

Q37131910-60BB01F7-3B86-4370-B02E-700574044B9A

P407

Q37131910-CDC41615-711F-4E08-A181-26204C58301D

P433

Q37131910-AC5F8056-53B9-44B4-B74B-4AA5A9BC881D

P478

Q37131910-2D0CAB4A-7555-486A-81CC-3427937EB05A

P50

Q37131910-38FF266E-6D03-44CB-B9FD-5FF8D1820B90

P577

Q37131910-3AE37EB6-2873-4675-94F9-E44A7C2064B4

P5875

Q37131910-1279D7B2-7189-4E80-8E43-4E36DC7B39EC

P698

Q37131910-CD71800A-9E0F-465A-85FD-67A73E29F481

P932

Q37131910-BDF34F39-7A9E-4833-ADAF-84FC9DC9CC50

P356

P1433

The Journal of Infectious Diseases

P1476

Primary vaccine failure after 1 dose of varicella vaccine in healthy children.

@en

P2093

Ann M Arvin

http://www.w3.org/2001/XMLSchema#string

Anne A Gershon

http://www.w3.org/2001/XMLSchema#string

David E Michalik

http://www.w3.org/2001/XMLSchema#string

Haley A Gans

http://www.w3.org/2001/XMLSchema#string

Peter F Wright

http://www.w3.org/2001/XMLSchema#string

Philip S Larussa

http://www.w3.org/2001/XMLSchema#string

Sharon P Steinberg

http://www.w3.org/2001/XMLSchema#string

P2860

Chickenpox outbreak in a highly vaccinated school population

Loss of vaccine-induced immunity to varicella over time

Live vaccine used to prevent the spread of varicella in children in hospital.

Antibody assays suitable for assessing immune responses to live varicella vaccine.

Importance of catch-up vaccination: experience from a varicella outbreak, Maine, 2002-2003.

Comparison of five assays for antibody to varicella-zoster virus and the fluorescent-antibody-to-membrane-antigen test.

Evaluation of the anticomplement immunofluorescence test for detection of antibody to varicella-zoster virus.

Antibody to Varicella-Zoster virus in parturient women and their offspring during the first year of life.

One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?

Seroepidemiologic survey of varicella: Value of specific fluorescent antibody test.

P304

944-949

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/529043

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

197

http://www.w3.org/2001/XMLSchema#string

P50

Kathryn M. Edwards

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5432216

http://www.w3.org/2001/XMLSchema#string

P698

18419532

http://www.w3.org/2001/XMLSchema#string

P932

2657090

http://www.w3.org/2001/XMLSchema#string